Delirium in the Intensive Care Unit: A Review

Neurologic Clinics

Volumn 29, Issue 4, 2011, Pages 749-763

  Morandi, Alessandro ^a,b,c   Jackson, James C ^a,d,e  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Ancelle della Carita Hospital   (Italy)

^c GERIATRIC RESEARCH GROUP   (Italy)

^d VA Tennessee Valley   (United States)

^e Education and Clinical Center (GRECC)   (United States)

Author keywords

Antipsychotics; Delirium; Intensive care unit; Multicomponent treatment; Pharmacologic treatment; Prevention; Risk factors; Sedation

Indexed keywords

DEXMEDETOMIDINE; DONEPEZIL; DOPAMINE; HALOPERIDOL; LORAZEPAM; NORADRENALIN; OLANZAPINE; PLACEBO; PROPOFOL; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; SEROTONIN; ZIPRASIDONE;

DELIRIUM; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; NEUROIMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPSIS; SINGLE DRUG DOSE;

DELIRIUM; HUMANS; INFLAMMATION; INTENSIVE CARE UNITS; NEUROIMAGING; RISK FACTORS; SEPSIS;

EID: 80055116026     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2011.08.004     Document Type: Review

References (95)

1. Ely E.W., Inouye S.K., Bernard G.R., et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001, 286(21):2703-2710.
2. Bergeron N., Dubois M.J., Dumont M., et al. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 2001, 27(5):859-864.
3. Ely E.W., Margolin R., Francis J., et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001, 29(7):1370-1379.
4. Dubois M.J., Bergeron N., Dumont M., et al. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med 2001, 27(8):1297-1304.
5. Ely E.W., Gautam S., Margolin R., et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001, 27(12):1892-1900.
6. Ouimet S., Kavanagh B.P., Gottfried S.B., et al. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med 2007, 33(1):66-73.
7. Thomason J.W., Shintani A., Peterson J.F., et al. Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients. Crit Care 2005, 9(4):R375-R381.
8. Milbrandt E.B., Deppen S., Harrison P.L., et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004, 32(4):955-962.
9. Ely E.W., Shintani A., Truman B., et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004, 291(14):1753-1762.
10. Lin S.M., Liu C.Y., Wang C.H., et al. The impact of delirium on the survival of mechanically ventilated patients. Crit Care Med 2004, 32(11):2254-2259.
11. McNicoll L., Pisani M.A., Inouye S.K. One-year outcomes following delirium in older ICU patients. J Am Geriatr Soc 2004, 52:S2.
12. Jackson J.C., Gordon S.M., Hart R.P., et al. The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol Rev 2004, 14(2):87-98.
13. Jackson J.C., Gordon S.M., Girard T.D., et al. Delirium as a risk factor for long term cognitive impairment in mechanically ventilated ICU survivors. Am J Respir Crit Care Med 2007, 175:A22.
14. American Psychiatric Association Diagnostic and statistical manual of mental disorders, text revision 2000, American Psychiatric Association, Washington, DC. 4th edition.
15. Farrell K.R., Ganzini L. Misdiagnosing delirium as depression in medically ill elderly patients. Arch Intern Med 1995, 155(22):2459-2464.
16. Lipowski Z.J. Delirium in the elderly patient. N Engl J Med 1989, 320(9):578-582.
17. Lipowski Z.J. Delirium: acute confusional states 1990, Rev. ed, Oxford University Press, New York.
18. Meagher D.J., Trzepacz P.T. Motoric subtypes of delirium. Semin Clin Neuropsychiatry 2000, 5(2):75-85.
19. Peterson J.F., Pun B.T., Dittus R.S., et al. Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc 2006, 54(3):479-484.
20. Cole M., McCusker J., Dendukuri N., et al. The prognostic significance of subsyndromal delirium in elderly medical inpatients. J Am Geriatr Soc 2003, 51(6):754-760.
21. Levkoff S.E., Liptzin B., Cleary P.D., et al. Subsyndromal delirium. Am J Geriatr Psychiatry 1996, 4:320-329.
22. Levkoff S.E., Yang F.M., Liptzin B. Delirium: the importance of subsyndromal states. Prim Psychiatr 2004, 11:40-44.
23. Marcantonio E.R., Ta T., Duthrie E., et al. Delirium severity and psychomotor types: their relationship with outcomes after hip fracture repair. J Am Geriatr Soc 2002, 50:850-857.
24. Ouimet S., Riker R., Bergeon N., et al. Subsyndromal delirium in the ICU: evidence for a disease spectrum. Intensive Care Med 2007, 33(6):1007-1013.
25. Inouye S.K., van Dyck C.H., Alessi C.A., et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990, 113(12):941-948.
26. Ely E.W., Truman B., Shintani A., et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003, 289(22):2983-2991.
27. Sessler C.N., Gosnell M.S., Grap M.J., et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002, 166(10):1338-1344.
28. Flacker J.M., Lipsitz L.A. Serum anticholinergic activity changes with acute illness in elderly medical patients. J Gerontol A Biol Sci Med Sci 1999, 54(1):M12-M16.
29. Gunther M.L., Morandi A., Ely E.W. Pathophysiology of delirium in the intensive care unit. Crit Care Clin 2008, 24(1):45-65. viii.
30. Inouye S.K., Ferrucci L. Elucidating the pathophysiology of delirium and the interrelationship of delirium and dementia. J Gerontol A Biol Sci Med Sci 2006, 61(12):1277-1280.
31. Van Der Mast R.C. Pathophysiology of delirium. J Geriatr Psychiatry Neurol 1998, 11:138-145.
32. Trzepacz P.T. Delirium. Advances in diagnosis, pathophysiology, and treatment. Psychiatr Clin North Am 1996, 19(3):429-448.
33. Trzepacz P.T. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000, 5:132-148.
34. Gunther M.L., Jackson J.C., Wesley E.E. Loss of IQ in the ICU brain injury without the insult. Med Hypotheses 2007, 69(6):1179-1182.
35. Robertsson B., Olsson L., Wallin A. Occurrence of delirium in different regional brain syndromes. Dement Geriatr Cogn Disord 1999, 10(4):278-283.
36. Fong T.G., Bogardus S.T., Daftary A., et al. Cerebral perfusion changes in older delirious patients using 99mTc HMPAO SPECT. J Gerontol A Biol Sci Med Sci 2006, 61(12):1294-1299.
37. Yokota H., Ogawa S., Kurokawa A., et al. Regional cerebral blood flow in delirium patients. Psychiatry Clin Neurosci 2003, 57(3):337-339.
38. Alsop D.C., Fearing M.A., Johnson K., et al. The role of neuroimaging in elucidating delirium pathophysiology. J Gerontol A Biol Sci Med Sci 2006, 61(12):1287-1293.
39. Hopkins R.O., Gale S.D., Weaver L.K. Brain atrophy and cognitive impairment in survivors of acute respiratory distress syndrome. Brain Inj 2006, 20(3):263-271.
40. Koponen H., Hurri L., Stenback U., et al. Computed tomography findings in delirium. J Nerv Ment Dis 1989, 177(4):226-231.
41. Goyette R.E., Key N.S., Ely E.W. Hematologic changes in sepsis and their therapeutic implications. Semin Respir Crit Care Med 2004, 25:645-659.
42. Opal S.M., Esmon C.T. Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003, 7(1):23-38.
43. Terborg C., Schummer W., Albrecht M., et al. Dysfunction of vasomotor reactivity in severe sepsis and septic shock. Intensive Care Med 2001, 27(7):1231-1234.
44. Sharshar T., Carlier R., Bernard F., et al. Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med 2007, 33(5):798-806.
45. Hellstrom I.C., Danik M., Luheshi G.N., et al. Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-beta-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons. Hippocampus 2005, 15(5):656-664.
46. Han L., McCusker J., Cole M., et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001, 161(8):1099-1105.
47. Balan S., Leibovitz A., Zila S.O., et al. The relation between the clinical subtypes of delirium and the urinary level of 6-SMT. J Neuropsychiatry Clin Neurosci 2003, 15:363-366.
48. Flacker J.M., Lipsitz L.A. Large neutral amino acid changes and delirium in febrile elderly medical patients. J Gerontol A Biol Sci Med Sci 2000, 55:B249-B252.
49. Van Der Mast R.C., van den Broek W.W., Fekkes D., et al. Incidence of and preoperative predictors for delirium after cardiac surgery. J Psychosom Res 1999, 46:479-483.
50. Bloom F.E., Kupfer D.J., Bunney B.S., et al. Amines. Psychopharmacology: the fourth generation of progress 1995, Raven Press, New York, p. 1287-359.
51. Pandharipande P., Shintani A., Peterson J., et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006, 104(1):21-26.
52. Pandharipande P.P., Pun B.T., Herr D.L., et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007, 298(22):2644-2653.
53. Marcantonio E.R., Juarez G., Goldman L., et al. The relationship of postoperative delirium with psychoactive medications. JAMA 1994, 272(19):1518-1522.
54. Pandharipande P., Cotton B.A., Shintani A., et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 2008, 65(1):34-41.
55. Corder E.H., Saunders A.M., Strittmatter W.J., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261(5123):921-923.
56. Ely E.W., Girard T.D., Shintani A.K., et al. Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit Care Med 2007, 35(1):112-117.
57. van Munster B.C., Korevaar J.C., de Rooij S.E., et al. The association between delirium and the apolipoprotein E e{open}4 allele in the elderly. Psychiatr Genet 2007, 17(5):261-266.
58. Aldemir M., Ozen S., Kara I.H., et al. Predisposing factors for delirium in the surgical intensive care unit. Crit Care 2001, 5(5):265-270.
59. McNicoll L., Pisani M.A., Zhang Y., et al. Delirium in the intensive care unit: occurrence and clinical course in older patients. J Am Geriatr Soc 2003, 51(5):591-598.
60. Inouye S.K., Charpentier P.A. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996, 275(11):852-857.
61. Inouye S.K. Predisposing and precipitating factors for delirium in hospitalized older patients. Dement Geriatr Cogn Disord 1999, 10(5):393-400.
62. Schor J.D., Levkoff S.E., Lipsitz L.A., et al. Risk factors for delirium in hospitalized elderly. JAMA 1992, 267(6):827-831.
63. Jacobi J., Fraser G.L., Coursin D.B., et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002, 30(1):119-141.
64. Aurell J., Elmqvist D. Sleep in the surgical intensive care unit: continuous polygraphic recording of sleep in nine patients receiving postoperative care. Br Med J (Clin Res Ed) 1985, 290(6474):1029-1032.
65. Gabor J.Y., Cooper A.B., Crombach S.A., et al. Contribution of the intensive care unit environment to sleep disruption in mechanically ventilated patients and healthy subjects. Am J Respir Crit Care Med 2003, 167(5):708-715.
66. Inouye S.K. Prevention of delirium in hospitalized older patients: risk factors and targeted intervention strategies. Ann Med 2000, 32(4):257-263.
67. Inouye S.K., Bogardus S.T., Charpentier P.A., et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999, 340(9):669-676.
68. Marcantonio E.R., Flacker J.M., Wright R.J., et al. Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc 2001, 49(5):516-522.
69. Lundstrom M., Edlund A., Karlsson S., et al. A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. J Am Geriatr Soc 2005, 53(4):622-628.
70. Milisen K., Foreman M.D., Abraham I.L., et al. A nurse-led interdisciplinary intervention program for delirium in elderly hip-fracture patients. J Am Geriatr Soc 2001, 49:523-532.
71. Kalisvaart K.J., de Jonghe J.F., Bogaards M.J., et al. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005, 53(10):1658-1666.
72. Prakanrattana U., Prapaitrakool S. Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 2007, 35(5):714-719.
73. Liptzin B., Laki A., Garb J.L., et al. Donepezil in the prevention and treatment of post-surgical delirium. Am J Geriatr Psychiatry 2005, 13(12):1100-1106.
74. Dautzenberg P.L., Mulder L.J., Olde Rikkert M.G., et al. Delirium in elderly hospitalised patients: protective effects of chronic rivastigmine usage. Int J Geriatr Psychiatry 2004, 19(7):641-644.
75. American Psychiatric Association Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999, 156(Suppl 5):1-20.
76. Breitbart W., Tremblay A., Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002, 43:175-182. [abstract].
77. Horikawa N., Yamazaki T., Miyamoto K., et al. Treatment for delirium with risperidone: results of a prospective open trial with 10 patients. Gen Hosp Psychiatry 2003, 25(4):289-292.
78. Kim K.S., Pae C.U., Chae J.H., et al. An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry Clin Neurosci 2001, 55(5):515-519.
79. Kim K.Y., Bader G.M., Kotlyar V., et al. Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 2003, 16(1):29-31.
80. Lee K.U., Won W.Y., Lee H.K., et al. Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study. Int Clin Psychopharmacol 2005, 20(6):311-314.
81. Mittal D., Jimerson N.A., Neely E.P., et al. Risperidone in the treatment of delirium: results from a prospective open-label trial. J Clin Psychiatry 2004, 65(5):662-667.
82. Pae C.U., Lee S.J., Lee C.U., et al. A pilot trial of quetiapine for the treatment of patients with delirium. Hum Psychopharmacol 2004, 19(2):125-127.
83. Parellada E., Baeza I., de Pablo J., et al. Risperidone in the treatment of patients with delirium. J Clin Psychiatry 2004, 65:348-353.
84. Sasaki Y., Matsuyama T., Inoue S., et al. A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry 2003, 64(11):1316-1321.
85. Sipahimalani A., Masand P.S. Olanzapine in the treatment of delirium. Psychosomatics 1998, 39:422-430.
86. Skrobik Y.K., Bergeron N., Dumont M., et al. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004, 30(3):444-449.
87. Han C.S., Kim Y.K. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004, 45(4):297-301.
88. Devlin J.W., Roberts R.J., Fong J.J., et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010, 38(2):419-427.
89. Girard T.D., Pandharipande P.P., Carson S.S., et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med 2010, 38(2):428-437.
90. Gill S.S., Bronskill S.E., Normand S.L., et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007, 146(11):775-786.
91. Rochon P.A., Normand S.L., Gomes T., et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008, 168(10):1090-1096.
92. Schneider L.S., Dagerman K.S., Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005, 294(15):1934-1943.
93. Wang P.S., Schneeweiss S., Avorn J., et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005, 353(22):2335-2341.
94. Flaherty J.H., Rudolph J., Shay K., et al. Delirium is a serious and under-recognized problem: why assessment of mental status should be the sixth vital sign. J Am Geriatr Soc 2007, 8(5):273-275.
95. Bergmann M.A., Murphy K.M., Kiely D.K., et al. A model for management of delirious postacute care patients. J Am Geriatr Soc 2005, 53(10):1817-1825.